About
Research
Patient Care
Education
Community
Aug 13, 2021
BTK Inhibitors Represent the Preferred Frontline Regimen in CLL
The majority of patients with newly diagnosed chronic lymphocytic leukemia (CLL) have better outcomes with BTK inhibitors compared with standard chemoimmunotherapy, making them the logical choice for frontline therapy, explained Susan O’Brien, MD, in a virtual presentation during the 2021 Pan Pacific Lymphoma Conference.
Jul 30, 2021
NIH Diversity Award Supports Loveless’ DNA Recorder to Study Drug Resistance in Breast Cancer Cells
Liu, associate professor of biomedical engineering and director of the Liu Laboratory for Synthetic Evolution where Loveless currently works, said, “Theresa’s research is motivated by a fundamental question in developmental biology: How does a cell’s past experiences shape its present? The K99 award will support Theresa’s development of a new genetic technology that will let us answer that question in vivo.”
Jun 01, 2021
UCI Health cancer care expansion gets $20 million from long-time benefactor
Behind the name on the building that will open a couple of years from now as UCI Health’s new cancer care center, next to the UC Irvine campus, is a more than 25-year commitment — and a $20 million gift toward expanding access to that care. The gift is the single biggest donation toward what will be known as the Chao Family Comprehensive Cancer Center and Ambulatory Care at the new UCI Medical Center in Irvine. And it brings the Chao family’s financial commitment to fighting cancer at UCI Health to a whopping $50 million since 1995.
May 17, 2021
PD-1 Inhibitor Prevails in Recurrent/Metastatic Cervical Cancer
The chemotherapy-free treatment was associated with significantly better quality of life, reported Krishnansu S. Tewari, MD, of the University of California Irvine, during a European Society for Medical Oncology Virtual Plenary.
May 03, 2021
UCI students employ photovoice technique to document reality in O.C.’s Asian American and Pacific Islander community during pandemic
The students recently showcased their work in a virtual exhibition titled “Through Our Eyes, Hear Our Stories.” The final product was the result of half a year of work and campuswide collaboration among the School of Humanities, the Department of Epidemiology & Biostatistics, UCI Libraries, the Chao Family Comprehensive Cancer Center and six local nonprofit organizations.
Apr 29, 2021
Grand Opening UCI Prostate Cancer Center: Care You Can Count On
UCI Urology has announced the grand opening of the UCI Comprehensive Prostate Cancer Center, a newly formed multidisciplinary clinic including prostate cancer experts from urology, medical oncology, radiation oncology, diagnostic radiology, and pathology at UCI Health. All of these specialists collaborate with the common goal of providing the highest quality personalized cancer care in a unique comfortable environment.
Metastatic breast cancer patient benefits from clinical trial research
Alberta Bustamante came to UCI Health in a wheelchair. The metastatic breast cancer patient is walking again thanks to an early-phase clinical trial funded by a National Cancer Institute (NCI) grant to boost enrollment of racial and ethnic minorities in such research.
Apr 21, 2021
Not all Asian Americans are being vaccinated at high rates. A Chinatown clinic shows why
When the vaccines became available, she and fellow community leaders — including Jack Cheng, director of operations of the Chinatown Service Center, which has medical clinics in Chinatown and San Gabriel, and Cevadne Lee, a director of community outreach and engagement at UC Irvine’s Chao Family Comprehensive Cancer Center who works on Asian American health equity efforts in L.A. and Orange counties — quickly realized there were efforts in place by the government to target Latino, Black and Native American communities.
Kay Family Foundation gives $1.3 million to UCI Center for Healthspan Sciences
Elim Kay, president of the Kay Family Foundation, said: “Dr. Mahtab Jafari’s cutting-edge healthspan program is the ideal setting to collaborate on developing the unique health coaching program. We look forward to the outcome of this program so that patients – more specifically, patients with cancer – can benefit from it.”
Mar 17, 2021
Find out how metabolomics-based approaches are revealing tumor microenvironment secrets
In this article, we speak with Dr. Chris Halbrook, assistant professor in the Department of Molecular Biology and Biochemistry at University of California, Irvine (UCI) and speaker at the SelectScience® Virtual Cancer and Immunology Research Summit in May 2021, about his work to identify mechanisms through LC/MS metabolomics-based approaches to help manage pancreatic cancer pathogenesis and ultimately improve patient welfare.